Organization · Venture Capital
AIF
The Autism Impact Fund (AIF) is a US-based venture capital firm focused on investing in technology and clinical provider organizations that advance treatment for neurodivergent individuals, particularly those with autism and related mental health challenges.
Overview
What AIF does
What AIF is
The Autism Impact Fund (AIF) is a US-based venture capital firm focused on investing in technology and clinical provider organizations that advance treatment for neurodivergent individuals, particularly those with autism and related mental health challenges.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2020
- Approximate age
- About 6 years
- Structured capabilities
- Funder
- Last reviewed
- April 9, 2026
Official channels
Find AIF elsewhere
Open the official website or a supported primary organization account.
Capability profile
AIF as a funder
Investment thesis
The Autism Impact Fund (AIF) invests in technology and innovation to improve treatment for neurodivergent individuals, particularly those with autism, while addressing broader mental and behavioral health challenges.
Focus narrative
AIF invests in early- and growth-stage companies that are innovating in the fields of behavioral health, mental health, and complex chronic conditions. The firm targets sectors such as diagnostics, digital health, therapeutics, and care delivery, emphasizing the need to address gaps and inefficiencies in these markets, which represent a significant economic opportunity.
Value beyond capital
AIF provides strategic support to its portfolio companies through partnerships, industry expertise, and access to a network of healthcare professionals and organizations. The firm emphasizes value-based care models and technology-enabled solutions to enhance treatment outcomes for neurodivergent individuals.
Terms and economics
- Typical check
- $100,000–$5,000,000
- Sweet spot
- $1,500,000
Focus and fit
- Stages
- Seed · Series A · Bridge · Growth Equity
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 8
Portfolio context
Auticon: An ICT firm employing neurodiverse adults as data technology solution providers. BioROSA: Developing a blood test for early detection of autism spectrum disorder (ASD) in children. Bluebird Kids Health: A pediatric platform improving access to care for children covered by Medicaid and CHIP. Camber: A software solution for behavioral health clinicians aimed at improving care quality and operational efficiency. Cortica: A comprehensive care provider addressing both behavioral and medical conditions for children and families. Eleplan: A caregiving platform centralizing care coordination for families managing complex health needs. Floreo: A virtual reality platform for teaching social and behavioral skills to individuals with ASD. Healios (Meliora Health): A telehealth service specializing in autism and ADHD care, focusing on reducing wait times for diagnostics and treatment.
Common questions
What to know about AIF
Upseed classifies AIF under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 9, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.